GALECTIN THERAPEUTICS INC

GALT · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.1B · 9 employees
344
SEC Filings
$4.14
Close 2026-09-22
9
Employees

Business Summary

Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company developing therapies for fibrotic disease and cancer by targeting galectin proteins, particularly galectin-3. Its lead drug candidate, belapectin (GR-MD-02), is a patented, plant-derived complex carbohydrate compound being developed for MASH cirrhosis (prevention of esophageal varices) and head and neck squamous cell carcinoma. The company completed its Phase 2b/3 NAVIGATE trial in 2024 and also conducts small molecule galectin-3 inhibitor research through its majority-owned subsidiary, Galectin Sciences LLC.

Latest Stock Quote

GALT 2026-09-22 $4.14 O:$4.05 H:$4.24 L:$4.0498 Vol:0.3M VWAP:$4.1463
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-09

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001140361-26-012155EDGAR63K words
2025-03-312024-12-310001140361-25-011169EDGAR64K words
2024-03-292023-12-310001140361-24-016452EDGAR60K words
2023-03-302022-12-310001140361-23-014658EDGAR—
2022-03-312021-12-310001140361-22-012058EDGAR—
2021-03-312020-12-310001193125-21-101402EDGAR—
2020-03-162019-12-310001193125-20-073907EDGAR—
2019-03-062018-12-310001193125-19-064705EDGAR—
2018-03-292017-12-310001193125-18-100592EDGAR—
2017-03-282016-12-310001193125-17-098753EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-142026-06-300001140361-26-032945EDGAR25K words
2025-11-142025-09-300001140361-25-042116EDGAR24K words
2025-08-142025-06-300001140361-25-031039EDGAR24K words
2025-05-152025-03-310001140361-25-019149EDGAR21K words
2024-11-142024-09-300001140361-24-046726EDGAR22K words
2024-08-132024-06-300001140361-24-036937EDGAR21K words
2024-05-152024-03-310001140361-24-026105EDGAR18K words
2023-11-132023-09-300001140361-23-052729EDGAR20K words
2023-08-142023-06-300001140361-23-039411EDGAR19K words
2023-05-152023-03-310001140361-23-024499EDGAR—
2022-11-142022-09-300001140361-22-041167EDGAR—
2022-08-152022-06-300001140361-22-029555EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-140001140361-26-032946EDGAR2K words
2026-08-040001140361-26-031058EDGAR1K words
2026-03-310001140361-26-012158EDGAR2K words
2026-03-170001140361-26-009735EDGAR1K words
2026-01-210001140361-26-001866EDGAR1K words
2026-01-120001140361-26-000994EDGAR0K words
2025-12-190001140361-25-046115EDGAR1K words
2025-12-080001140361-25-044711EDGAR1K words
2025-12-030001140361-25-044148EDGAR2K words
2025-11-140001140361-25-042118EDGAR2K words

344 total filings indexed. 312 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

fibrotic-liver-disease-(mash/nash-cirrhosis) cancer-immunotherapy-(melanoma,-head-and-neck-squamous-cell-carcinoma) portal-hypertension esophageal-varices-prevention baveno-vii-criteria-for-portal-hypertension-assessment fibroscan-liver-stiffness-measurement-(lsm) elf-(enhanced-liver-fibrosis)-score

Company Identity

CIK0001133416
TickerGALT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV
HeadquartersAtlanta, GA (suburb)
Websitehttps://www.galectintherapeutics.com
Listed2002-09-04

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: dcdb9391de34bb3ce2e9aacf8e12edf08f51b85c3afc468ac3af5ecdb38ceedb
parent: 582dd027d1dd82c9ef18d194461dcd9166ea4ea982c89c8c3a7e6a0681069e81
content hash: 49f63d5eaca3772aa371a2cbc4ccd608f525afd04916630be1771acb460392c3
signed: 2026-09-28T12:01:23.177Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up GALT using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on GALT, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/GALT (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.